http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011073408-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12630d8b68a89d717b8a1e154c04125d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adf9e50163ce436813c4b45e883f5f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2fd608e2502870384abc13bfbb3377e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78f10c5588215c370b2d84187fff2dd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa47e81f6828d8cf88f4951cd66a73da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aacf09800622d8fc2a61c20f4acd8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5466ad170ec76bde032c08f067bfe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e3e8023522ccf25b80900a7aece3751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
filingDate 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb00ecc9a98ab46d30003d7e400e5cb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b532f21f774e51b0e22d3b79e67049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb7a04e605c3e9ea9f3ae1cbf0a65500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_350b8ba93aa41dfb9649900cd15dc1d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05b75091c3501d7d297057af9869dc37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_336917323e7dea41f8d7d1f43fe7da1e
publicationDate 2012-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011073408-A3
titleOfInvention Pharmaceutical oral dosage form containing a synthetic oligosaccharide
abstract The present invention concerns a pharmaceutical formulation intended for oral administration containing a synthetic oligosaccharides containing one to 18 monosaccharide units and having a therapeutical activity or a pharmaceutically acceptable additions salt or solvate thereof wherein the formulation contains: a) the synthetic oligosaccharide (A) in an amount of up to 5% by weight of the total weight of the formulation, advantageously up to 1 % by weight of the total weight of the formulation, b) a lipophilic phase (B) consisting of triglyceride of fatty acids in an amount of 50 to 80% by weight of the total weight of the formulation, advantageously of 50 to 70 % by weight of the total weight of the formulation, c) at least one lipophilic surfactant (C) with HLB below 7 consisting of partial esters of polyol and fatty acids in an amount of 10 to 30% by weight of the total weight of the formulation, advantageously of 15 to 30 % by weight of the total weight of the formulation, d) at least one hydrophilic surfactant (D) with HLB above 7 in an amount of up to 20% by weight of the total weight of the formulation, advantageously up to 15% by weight of the total weight of the formulation, e) optionally, at least one hydrophilic solvent (E) in an amount of up to 15% by weight of the total weight of the formulation, advantageously up to 10% by weight of the total weight of the formulation, f) between 0 and 30% by weight of the total weight of the formulation of a chemical and/or physical stabilization agent (F), advantageously between 0 and 20 % by weight of the total weight of the formulation, wherein when the formulation is in a form of a reverse emulsion or microemulsion and contains at least one hydrophilic solvent (E), the physical stabilization agent is present and is silicon dioxide.
priorityDate 2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02053100-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002032171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5626869-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261

Total number of triples: 36.